Vitamin C has spent half a century at the center of one of the most bitter disputes in nutritional science, and the man who championed it paid a heavy professional price.

Only one person in history has won two unshared Nobel Prizes in different fields. Linus Pauling, awarded the 1954 Nobel Prize in Chemistry and the 1962 Nobel Peace Prize, was a founding figure of quantum chemistry and molecular biology, a scientist whose theoretical reasoning anticipated major breakthroughs across molecular science.

Yet the final 25 years of his life were overshadowed by ridicule from the medical community. Textbooks and popular science writing long presented him as a cautionary tale of a brilliant scientist who drifted into supplement pseudoscience, simply because he insisted that vitamin C could help the body resist aging, chronic disease, and cancer.

Colleagues attacked him as stubborn and dismissive of controlled trials. The public remembered his claims about grams of daily supplements for colds and cancer, while largely overlooking the deeper framework behind them: the idea that nutrient balance determines how quickly the human body ages.

Over the past decade and a half, however, the evidence has moved steadily in his favor. Studies spanning skin epigenetics, cognition in older adults, muscle retention after 50, cardiovascular health, hypertension, metabolic syndrome, and tumor biology have each added support for the protective value of vitamin C across the whole body.

Half a century later, a fair question deserves an honest answer: was Pauling a thinker whose ideas ran decades ahead of his time?

01 A Two-Time Nobel Laureate Undone by Vitamin C

The first half of Pauling’s career was a scientific legend that may never be repeated. His work on the chemical bond and molecular structure earned him the 1954 Nobel Prize in Chemistry, and his lifelong campaign against nuclear weapons earned the Nobel Peace Prize. Fellow scientists described him as a thinker who could anticipate major discoveries through reasoning alone.

The turning point came in 1966. A letter from Irwin Stone, a self-described biochemical researcher, suggested that taking several grams of vitamin C each day could substantially extend life. After trying the regimen himself, Pauling reported far fewer colds and greater energy. He devoted the rest of his career to the subject and founded orthomolecular medicine. Its central proposition: aging and chronic disease essentially reflect imbalances in the concentrations of key nutrient molecules, and restoring optimal levels could address degeneration at its root.

He then published a book claiming that 1 to 10 grams of vitamin C daily could sharply reduce the incidence of colds. The book became a bestseller, roughly a quarter of Americans began supplementing, and mainstream nutrition scientists pushed back hard. Multiple double-blind trials found that large oral doses do not prevent colds and only modestly shorten their duration.

Together with a surgeon colleague, he published a paper claiming that 10 grams per day tripled survival time in terminal cancer patients. Two large double-blind trials at the Mayo Clinic refuted that conclusion.

In his later years he proposed a provocative evolutionary theory: humans had lost the gene for synthesizing their own vitamin C, and atherosclerosis was an ancient compensatory mechanism born of chronic deficiency. Few took the idea seriously.

Then came the darkest chapter. A protege who had worked with him for 16 years found that ultrahigh-dose supplementation promoted skin tumors in mice. Pauling refused to accept the data, forced the younger scientist out, and the dispute ended in litigation and a large settlement. From then on he carried a permanent label: brilliant, but incapable of admitting error.

For decades afterward, science communication treated his late career as a tragedy, the story of a giant who fell for a supplement obsession.

02 Vitamin C Research Now Spans Every System of the Body

An honest assessment requires a clear distinction. Modern research does not support Pauling’s extreme claims that megadose oral supplementation cures cancer or eliminates colds. But two decades of rigorous studies do support his deeper prediction: that vitamin C is a core anti-aging nutrient acting across the whole body, and in many cases the mechanisms echo his reasoning almost directly.

Vitamin C and Cardiovascular Health

In 2015, the University of Copenhagen published a study in the American Journal of Clinical Nutrition covering roughly 100,000 Danes. Those with the highest fruit and vegetable intake — whose blood vitamin C concentrations were correspondingly higher — had a 15% lower risk of cardiovascular disease and a 20% lower risk of early death than those who rarely ate them. Notably, the study’s Mendelian randomization analysis, the part designed to test whether vitamin C itself is causal, did not reach statistical significance. The finding therefore points to fruit and vegetables as a whole rather than to the vitamin alone, and it remains an association rather than proof of cause. As the body’s central water-soluble antioxidant, the vitamin maintains connective tissue in blood vessel walls and clears free radicals that damage them, which aligns closely with Pauling’s argument that deficiency drives vascular injury.

In 2012, Johns Hopkins University published a meta-analysis of 29 randomized controlled trials. An average of 500 mg per day, about five times the standard recommendation, lowered systolic blood pressure by 3.84 mmHg in the short term, and by nearly 5 mmHg among people with hypertension. With close to a third of adults worldwide living with high blood pressure, even small reductions translate into fewer strokes and heart attacks. The researchers noted that the nutrient may promote sodium excretion through the kidneys and help relax blood vessel walls.

In 2019, Oregon State University, home of the Linus Pauling Institute, published a review in Redox Biology on metabolic syndrome, a cluster of obesity, high blood pressure, high blood sugar, and abnormal blood lipids affecting roughly 35% of American adults. These patients show low blood vitamin C even when their intake matches everyone else’s. A high-fat diet damages the gut barrier, bacterial fragments enter circulation, and activated immune cells burn through the body’s antioxidant reserves, creating a cycle of inflammation and oxidative damage. Adequate vitamin C can interrupt that cycle, supporting antioxidant balance, insulin sensitivity, and vascular health. The review reads like direct experimental support for Pauling’s early claim that oxidative imbalance sits at the core of metabolic aging.

Vitamin C and Healthy Aging

In 2020, the University of East Anglia analyzed data from more than 13,000 adults aged 42 to 82. Higher dietary and circulating levels of the vitamin were associated with greater skeletal muscle mass. After age 50, people lose about 1% of their muscle each year, a decline linked to frailty, loss of independence, and type 2 diabetes. The nutrient protects muscle fibers from oxidative damage, and the researchers emphasized that an orange a day plus a serving of vegetables is enough, with no megadoses required.

In 2026, Hirosaki University published a cross-sectional study in PLoS ONE that measured plasma vitamin C and brain MRI scans in 2,044 Japanese adults over the age of 64 at a single point in time. Those in the lowest quartile of plasma vitamin C had about 2.3% less gray matter volume than those in the highest quartile, along with weaker connectivity in the default mode network, which supports memory and attention. The vitamin crosses the blood-brain barrier, helps control oxidative stress in the brain, and supports neurotransmitter synthesis. The study was observational, so it cannot establish cause and effect, and it was partly funded by a food company. Even so, it echoes Pauling’s belief that the nutrient nourishes the nervous system.

In 2025, the Tokyo Metropolitan Institute for Geriatrics and Gerontology published research in the Journal of Investigative Dermatology revealing a new pathway. The work was done in lab-grown human epidermal equivalents — cultured skin models, not people. Vitamin C sustained the activity of TET enzymes, which remove methyl groups from DNA. This demethylation reopened 10,138 previously methylated regions and raised the expression of 12 proliferation-related genes by anywhere from 1.6- to 75.2-fold, thickening the epidermal cell layer. That is epigenetic regulation driven by a nutrient, precisely the kind of mechanism Pauling’s orthomolecular framework proposed at a time when no technology existed to observe it. The study was conducted with a pharmaceutical company and has not yet been confirmed in human trials.

Vitamin C and Tumor Biology

In 2007, Johns Hopkins published a study in Cancer Cell identifying a molecular target. Rapidly growing tumors create oxygen-starved environments and depend on the HIF-1 protein to survive and to build new blood vessels. Vitamin C degrades HIF-1, cutting off the tumor’s oxygen and energy supply and inhibiting lymphoma and liver cancer cells in mice. Crucially, the study drew a boundary Pauling never could: oral dosing cannot reach effective concentrations in tumors, but intravenous infusion can achieve levels that selectively stress cancer cells while sparing normal ones. Cameron and Pauling had given vitamin C intravenously for the first ten days before switching to oral maintenance, while the Mayo trials used oral dosing from the start, so the two sides were not testing the same intervention. This helps explain why his clinical observations and the refuting trials were both partly correct.

03 Where Pauling Was Wrong, and Where He Was Ahead

The scientific boundaries must stay clear. Modern research supports adequate dietary vitamin C for whole-body protection during aging. It does not support megadose oral supplementation as a cure for cancer or the common cold. Oral absorption has a ceiling, and very high doses carry risks of diarrhea and kidney stones. Only intravenous infusion reaches the concentrations relevant to oncology and critical care, and that is a clinical decision rather than a supplement decision.

At the same time, his larger insights have aged remarkably well. He was among the first to tie a single nutrient to systemic aging and chronic disease, at a time when medicine treated vitamin C as nothing more than scurvy prevention. His orthomolecular logic, optimizing nutrient concentrations to influence physiology, now reads like a precursor of modern precision nutrition. And his evolutionary point, that humans lost the ability to synthesize the vitamin and depend entirely on diet, remains a working reference in evolutionary nutrition research.

04 A Visionary Ahead of His Time

Pauling never backed down. He took about 12 grams per day for the rest of his life and maintained until his death in 1994 that it slowed his aging and reduced his risk of serious disease, even as much of the scientific community kept its distance. He left behind a warning that still resonates: think for yourself, and do not accept claims on authority alone, even from a white-haired Nobel laureate.

Decades later, dozens of studies from leading universities and journals have gradually assembled the evidence he never had. The picture they form is not of a stubborn old man obsessed with supplements, but of a thinker who saw the connection between nutrition and aging half a century before the tools existed to verify it.

Science rarely arrives at truth in a single step. Ideas that run ahead of their time often wait decades for evidence to catch up.

05 An Important Reminder About Vitamin C Use

This article summarizes published research and does not recommend megadose oral supplementation for any individual. Daily fruit and vegetables, such as oranges, kiwifruit, bell peppers, leafy greens, and berries, are sufficient for general health needs. People with kidney disease, a history of kidney stones, blood disorders, or cancer should consult a physician or clinical dietitian before using any supplement, and should not take high doses for extended periods without medical supervision.

References

Johns Hopkins Medical Institutions. (2007, September 12). How Vitamin C Stops Cancer. ScienceDaily. Original publication: Cancer Cell (2007).

https://www.sciencedaily.com/releases/2007/09/070910132848.htm

Johns Hopkins Medicine. (2012, April 18). Big doses of vitamin C may lower blood pressure. ScienceDaily. Original publication: Am J Clin Nutr. 2012;95(5):1079-1088. doi:10.3945/ajcn.111.027995

https://www.sciencedaily.com/releases/2012/04/120418111810.htm

University of Copenhagen, The Faculty of Health and Medical Sciences. (2015, July 7). Vitamin C related to reduced risk of cardiovascular disease, early death. ScienceDaily. Original publication: Am J Clin Nutr. 2015. doi:10.3945/ajcn.114.104497

https://www.sciencedaily.com/releases/2015/07/150707082350.htm

Oregon State University. (2019, January 2). Metabolic syndrome patients need more vitamin C to break cycle of antioxidant depletion. ScienceDaily. Original publication: Redox Biology (2019), narrative review.

https://www.sciencedaily.com/releases/2019/01/190102193748.htm

University of East Anglia. (2020, August 27). How vitamin C could help over 50s retain muscle mass. ScienceDaily. Original publication: J Nutr. 2020. doi:10.1093/jn/nxaa221

https://www.sciencedaily.com/releases/2020/08/200826200709.htm

Tokyo Metropolitan Institute for Geriatrics and Gerontology. (2025, June 25). Vitamin C flips your skin’s “youth genes,” reversing age-related thinning. ScienceDaily. Original publication: J Invest Dermatol. 2025. doi:10.1016/j.jid.2025.03.040

https://www.sciencedaily.com/releases/2025/06/250625075013.htm

Hirosaki University. (2026, June 26). Scientists discover a surprising link between vitamin C and brain health. ScienceDaily. Original publication: PLoS One. 2026;21(6):e0348504. doi:10.1371/journal.pone.0348504

https://www.sciencedaily.com/releases/2026/06/260626030428.htm

Disclaimer

These statements have not been evaluated by the Food and Drug Administration. This article is not intended to diagnose, treat, cure, or prevent any disease.